Switch to: Citations

Add references

You must login to add references.
  1. Informed Consent Procedures: Responsibilities of Researchers in Developing Countries.Soledad Sánchez, Gloria Salazar, Marcia Tijero & Soledad Díaz - 2001 - Bioethics 15 (5-6):398-412.
    We describe the informed consent procedures in a research clinic in Santiago, Chile, and a qualitative study that evaluated these procedures. The recruitment process involves information, counseling and screening of volunteers, and three or four visits to the clinic. The study explored the decision‐making process of women participating in contraceptive trials through 36 interviews. Women understood the research as experimentation or progress. The decision to participate was facilitated by the information provided; time to consider it and to discuss it with (...)
    Download  
     
    Export citation  
     
    Bookmark   12 citations  
  • Identifying structures, processes, resources and needs of research ethics committees in Egypt.Hany Sleem, Samer S. El-Kamary & Henry J. Silverman - 2010 - BMC Medical Ethics 11 (1):12-.
    Background: Concerns have been expressed regarding the adequacy of ethics review systems in developing countries. Limited data are available regarding the structural and functional status of Research Ethics Committees (RECs) in the Middle East. The purpose of this study was to survey the existing RECs in Egypt to better understand their functioning status, perceived resource needs, and challenges. Methods: We distributed a self-administered survey tool to Egyptian RECs to collect information on the following domains: general characteristics of the REC, membership (...)
    Download  
     
    Export citation  
     
    Bookmark   21 citations  
  • Evaluation of the quality of informed consent in a vaccine field trial in a developing country setting.Deon Minnies, Tony Hawkridge, Willem Hanekom, Rodney Ehrlich, Leslie London & Greg Hussey - 2008 - BMC Medical Ethics 9 (1):15-.
    BackgroundInformed consent is an ethical and legal requirement for research involving human participants. However, few studies have evaluated the process, particularly in Africa.Participants in a case control study designed to identify correlates of immune protection against tuberculosis (TB) in South Africa. This study was in turn nested in a large TB vaccine efficacy trial.The aim of the study was to evaluate the quality of consent in the case control study, and to identify factors that may influence the quality of consent.Cross-sectional (...)
    Download  
     
    Export citation  
     
    Bookmark   19 citations  
  • Informed consent in Ghana: what do participants really understand?Z. Hill, C. Tawiah-Agyemang, S. Odei-Danso & B. Kirkwood - 2008 - Journal of Medical Ethics 34 (1):48-53.
    Objectives: To explore how subjects in a placebo-controlled vitamin A supplementation trial among Ghanaian women aged 15–45 years perceive the trial and whether they know that not all trial capsules are the same, and to identify factors associated with this knowledge.Methods: 60 semistructured interviews and 12 focus groups were conducted to explore subjects’ perceptions of the trial. Steps were taken to address areas of low comprehension, including retraining fieldworkers. 1971 trial subjects were randomly selected for a survey measuring their knowledge (...)
    Download  
     
    Export citation  
     
    Bookmark   15 citations  
  • (1 other version)Defining and Describing Benefit Appropriately in Clinical Trials.Nancy M. P. King - 2000 - Journal of Law, Medicine and Ethics 28 (4):332-343.
    Institutional review boards and investigators are used to talking about risks of harm. Both low risks of great harm and high risks of small harm must be disclosed to prospective subjects and should be explained and categorized in ways that help potential subjects to understand and weigh them appropriately. Everyone on an IRB has probably spent time at meetings arguing over whether a three-page bulleted list of risk description is helpful or overkill for prospective subjects. Yet only a small fraction (...)
    Download  
     
    Export citation  
     
    Bookmark   67 citations  
  • Clinical research with economically disadvantaged populations.C. C. Denny & C. Grady - 2007 - Journal of Medical Ethics 33 (7):382-385.
    Concerns about exploiting the poor or economically disadvantaged in clinical research are widespread in the bioethics community. For some, any research that involves economically disadvantaged individuals is de facto ethically problematic. The economically disadvantaged are thought of as “venerable” to exploitation, impaired decision making, or both, thus requiring either special protections or complete exclusion from research. A closer examination of the worries about vulnerabilities among the economically disadvantaged reveals that some of these worries are empirically or logically untenable, while others (...)
    Download  
     
    Export citation  
     
    Bookmark   19 citations  
  • Ethical Oversight of Research in Developing Countries.Nancy Kass, Liza Dawson & Nilsa I. Loyo-Berrios - 2003 - IRB: Ethics & Human Research 25 (2):1.
    Download  
     
    Export citation  
     
    Bookmark   9 citations  
  • Health Research Ethics Committees in South Africa 12 years into democracy.Myer Landon & Moodley Keymanthri - 2007 - BMC Medical Ethics 8 (1):1-8.
    Background Despite the growth of biomedical research in South Africa, there are few insights into the operation of Research Ethics Committees (RECs) in this setting. We investigated the composition, operations and training needs of health RECs in South Africa against the backdrop of national and international guidelines. Methods The 12 major health RECs in South Africa were surveyed using semi-structured questionnaires that investigated the composition and functions of each REC as well as the operational issues facing committees. Results Health RECs (...)
    Download  
     
    Export citation  
     
    Bookmark   18 citations  
  • Assessing Benefits in Clinical Research: Why Diversity in Benefit Assessment Can Be Risky.Larry R. Churchill, Daniel K. Nelson, Gail E. Henderson, Nancy M. P. King, Arlene M. Davis, Erin Leahey & Benjamin S. Wilfond - 2003 - IRB: Ethics & Human Research 25 (3):1.
    Download  
     
    Export citation  
     
    Bookmark   11 citations